To determine whether the increase in ABCG1 and ABCA1 expression induced by 4-cholesten-3-one was LXR-dependent, we decided to suppress LXR activity in breast cancer cells using an SR9238 inverse agonist and to subsequently study the mRNA expression of LXR target genes, ABC transporters. The gene discussed is ABCG1; the disease is breast carcinoma.